Rutgers Announces New Heads of Medicine and Translational Science at Robert Wood Johnson Medical School

Rutgers Announces New Heads of Medicine and Translational Science at Robert Wood Johnson Medical School

Fredric Wondisford and Sally Radovick of Johns Hopkins designated chancellor scholars by Rutgers Biomedical and Health Sciences
Media Contact
Patricia M. Hansen
732-235-6307

Fredric E. Wondisford has been named professor of medicine and chair of medicine at Rutgers Robert Wood Johnson Medical School and chief of the department of medicine at Robert Wood Johnson University Hospital. Sally Radovick has been named professor of pediatrics and senior associate dean for clinical and translational research at Rutgers Robert Wood Johnson Medical School. Both will be chancellor scholars, a new designation awarded by the Rutgers Biomedical and Health Sciences chancellor to the academically strongest new recruits.

“We are pleased to welcome both Dr. Wondisford and Dr. Radovick to Robert Wood Johnson Medical School from Johns Hopkins University School of Medicine,” said Vicente H. Gracias, interim dean of the medical school. “Both of these esteemed physicians will allow us to advance the delivery of clinical care, research, education and community health in the local community as well as the national landscape.”

Image of Fredric E. Wondisford
Fredric E. Wondisford, professor and chair of medicine, Rutgers Robert Wood Johnson Medical School.
While at Johns Hopkins University School of Medicine,Wondisford served as professor of medicine, pediatrics and physiology and as director of the metabolism division. He also served as director of the Johns Hopkins Diabetes Institute, leading a multidisciplinary effort of research scientists and physicians to improve the quality of care for patients.

As a physician-scientist, Wondisford’s well-funded research program focuses on pituitary and pancreatic hormonal growth and regulation. He is the inventor of the approach to synthesize recombinant human TSH, for which he holds two U.S. patents. Recombinant human TSH (Thyrogen) is FDA-approved for use in the diagnosis and treatment of patients with thyroid cancer.

Wondisford earned a bachelor’s degree summa cum laude in biology and chemistry at Youngstown State University, Ohio, and a medical degree from Northeastern Ohio Universities College of Medicine. His residency in internal medicine was conducted at the University Hospitals of Cleveland and Case Western Reserve University Medical School. He completed a fellowship in endocrinology research at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md.

Radovick served as the Lawson Wilkins Professor of Pediatrics, director of the division of endocrinology and vice chair for research in the department of pediatrics at Johns Hopkins University School of Medicine.

Image of Sally Radovick
Sally Radovick, professor of pediatrics and senior associate dean for clinical and translational research, Rutgers Robert Wood Johnson Medical School.
An expert in pediatric growth and development disorders, Radovick’s well-funded research program focuses on steroids that control sexual maturity and reproduction, neurotransmitters and growth factors. In addition, she studies the deficiency of hormones produced by the pituitary gland in children with growth failure.

Radovick earned a bachelor’s degree cum laude, in biology and chemistry, and a master’s degree in theoretical chemistry from Youngstown State University, Ohio. She earned a medical degree from Northeastern Ohio Universities College of Medicine and completed a residency at Case Western Reserve University, Rainbow Babies and Children’s Hospital, Cleveland, Ohio. Radovick was a pediatric endocrinology fellow, developmental endocrinology branch at the National Institute of Child Health and Human Development and a senior staff fellow, molecular cellular and endocrinology branch at the National Institute of Diabetes, Digestive and Kidney Diseases, both part of the National Institutes of Health in Bethesda, Md.

“Dr. Wondisford and Dr. Radovick exemplify the strength of the newly integrated Rutgers to recruit international talent to our university,” says Brian Strom, chancellor of Rutgers Biomedical Health Sciences. “This is yet another step in the continuum of building for the state of New Jersey one of the best academic health centers in the country.”

Media Contact
Patricia M. Hansen
732-235-6307